Spotlight
Topic
News
Opinion
Brand Insights
Subscribe
Advertise
- Strategy
- Payers
- AI
- Cybersecurity
- Device Development
- Studies/Published Research
- Ethics
- Regulatory
- Digital Biomarkers
- Data Science
- Companion Diagnostics
- Clinical Care
- Digital Therapeutics
- Academic Research
- Virtual Reality
- RWE
- Digital Endpoints
- Medical Devices (Class II and Class III)
- Commercialization
- Clinical Trials
- Drug-Device Combinations
- SaMD
- Remote Patient Monitoring
- Patient Engagement
- Profiles/Q&A
FDA Seeks Comment on 3-D Printing of Medical Devices
The FDA published a discussion paper regarding 3-D printing medical devices at the point of care (PoC), such as hospitals and doctor’s offices, and is open for public comment until February 10. The discussion paper provides relevant background, brief overview of FDA regulation of devices and 3-D printing, and how capabilities at a 3-D printing facility factor into device safety and effectiveness. The comment period allows for a potential approach for regulatory oversight under various scenarios to inform future policy development.
Read more about the discussion paper.
Related Content
